A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 48/00 (2006.01) A61K 31/7088 (2006.01) A61K 31/7115 (2006.01) A61P 25/00 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2539727
Pharmaceutical compositions for treatment of CNS malignancies comprising a sequence of bases that is complementary to portions of both the gene encoding IGFBP-2 and the gene encoding IGFBP-5 are provided. Methods of using the pharmaceutical composition in the treatment of CNS malignancy via various modes of administration are also provided.
La présente invention concerne des compositions pharmaceutiques destinées au traitement des malignités atteignant le système nerveux central. Il s'agit d'une suite de bases qui est complémentaire de parties, non seulement du gène codant IGFBP-2, mais aussi du gène codant IGFBP-5. L'invention concerne également des procédés pour l'utilisation de la composition pharmaceutique pour le traitement des malignités atteignant le système nerveux central, en recourant à divers modes d'administration.
Gleave Martin E.
Levitt Randy J.
Pollak Michael N.
Smart & Biggar
The University Of British Columbia
LandOfFree
Bispecific oligonucleotide for the treatment of cns... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bispecific oligonucleotide for the treatment of cns..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bispecific oligonucleotide for the treatment of cns... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1856584